Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade

Circulation

Volumn 97, Issue 23, 1998, Pages 2302-2306

  Van 't Hof, Arnoud W J ^a   Liem, Aylee ^a   Suryapranata, Harry ^a   Hoorntje, Jan C A ^a   De Boer, Menko Jan ^a   Zijlstra, Felix ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

Angiography; Angioplasty; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0032537574     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.23.2302     Document Type: Article

References (24)

1. Fibrinolytic Therapy Trialists' (FTT) collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
2. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction: a review. Drugs. 1992;44:293-325.
3. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E. Thrombolysis in myocardial infarction (TIMI) trial, phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76:142-154.
4. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival, after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
5. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Stezelecki M, Puchrowicz-Ochoki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
6. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
7. Gibbons RJ, Holmes DR, Reeder GS, Bayley KR. Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
8. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no reflow" phenomenon. Circulation. 1996;93:223-228.
9. Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L, Rizzon P. Myocardial contrast echocardiography in acute myocardial infarction: pathophysiological background and clinical applications. Eur Heart J. 1996;17:344-353.
10. de Boer MJ, Reiber JHC, Suryapranata H, van den Brand MJBM, Hoorntje JCA, Zijlstra F. Angiographic findings and catheterisation laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Mean J. 1995;16:1347-1356.
11. Zijlstra F, Beukema WP, van 't Hof AWJ, Liem AL, Reiffers S, Hoorntje JCA, Suryapranata H, de Boer MJ. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1997;29:908-912.
12. Suryapranata H, van 't Hof AWJ, Hoorntje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in patients with acute myocardial infarction. Circulation. 1998. In press.
13. Little WC, Rogers EW. Angiographic evidence of hemorrhagic myocardial infarction after intracoronary thrombolysis with streptokinase. Am J Cardiol. 1983;51:906-908.
14. van 't Hof AWJ, Liem AL, de Boer MJ, Zijlstra F, for the Zwolle Myocardial Infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet. 1997;350:615-619.
15. van der Laarse A, Hermens WT, Hollaar L, Jol M, Willems GM, Lemmers HEAS, Liem AH, Souverijn JHM, Oudhof JH, De Hooge J, Buis B, Arntzenius AC. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum α-hydroxybutyrate dehydrogenase levels. Am Heart J. 1984;107:248-260.
16. Hermens WT, Willems GM, Nijssen KM, Simoons ML. Effect of thrombolytic treatment delay on myocardial infarct size. Lancet. 1992;340:1297. Letter.
17. Zijlstra F, de Boer MJ, Beukema WP, Liem AL, Reiffers S, Huysmans D, Hoorntje JCA, Suryapranata H, Simoons ML. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J. 1996;17:382-387.
18. Schlesselman JJ. Case-Control Studies. New York, NY: Oxford Press, 1982:203-206.
19. Suryapranata H, Zijlstra F, MacLeod DC, van den Brand M, de Feyter PJ, Serruys PW. Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction. Circulation. 1994;89:1109-1117.
20. Zijlstra F, Widimsky P, Suryapranata H. Possibilities and limitations of myocardial flow reserve. In: Reiber JHC, Serruys PW, eds. Progress in Quantitative Coronary Arteriography. Dordrecht. Netherlands: Kluwer Academics Publishers; 1994:141-159.
21. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negoro S, Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-1999.
22. Kloner RA, Ganote CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
23. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole K, Braunwald E. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation. 1996;93:879-888.
24. Forrester JS. New standard for success of thrombolytic therapy: an earnest proposal. Circulation. 1995;92:2026-2028.